• Users Online: 755
  • Print this page
  • Email this page

  Article Access Statistics

Year : 2022 | Volume:  5 | Issue Number:  3 | Page:  110-111

CORRIGENDUM

Corrigendum: Initial report of a clinical trial evaluating the safety and efficiency of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas: A prospective, phase II, single-arm study


Number of times this article was viewed 406
Number of times this article has been printed  from the site 10
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0
Back To Article